**Core Concept**
The management of co-infection with HIV and Tuberculosis (TB) requires careful consideration of the timing and sequencing of antiretroviral therapy (c-A.R.T) and anti-tubercular therapy (ATT). The goal is to initiate treatment that will effectively manage both infections while minimizing the risk of treatment failure, drug interactions, or immune reconstitution inflammatory syndrome (IRIS).

**Why the Correct Answer is Right**
In patients co-infected with HIV and TB, it is recommended to start ATT before initiating c-A.R.T. This is because ATT is essential to control the TB infection and prevent the spread of TB to others. Starting c-A.R.T early may lead to IRIS, which can worsen TB symptoms and make it harder to control the infection. By starting ATT first, the TB infection is brought under control, reducing the risk of IRIS and allowing for a safer initiation of c-A.R.T.

**Why Each Wrong Option is Incorrect**
**Option A:** This option suggests starting c-A.R.T first, which may lead to IRIS and worsen TB symptoms.
**Option B:** This option implies that ATT and c-A.R.T can be started simultaneously, which may increase the risk of drug interactions and IRIS.
**Option C:** This option suggests that ATT should be stopped once c-A.R.T is initiated, which is not recommended as TB infection may persist and lead to treatment failure.

**Clinical Pearl / High-Yield Fact**
In patients co-infected with HIV and TB, it is essential to start ATT before initiating c-A.R.T to prevent IRIS and ensure effective management of both infections.

**Correct Answer:** A. Start ATT before c-A.R.T.